These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


206 related items for PubMed ID: 6130864

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pharmacological basis for antihypertensive effects of intravenous labetalol.
    Richards DA, Prichard BN, Boakes AJ, Tuckman J, Knight EJ.
    Br Heart J; 1977 Jan; 39(1):99-106. PubMed ID: 12778
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of medroxalol and labetalol, drugs with combined alpha- and beta-adrenoceptor antagonist properties.
    Elliott HL, McLean K, Meredith PA, Sumner DJ, Reid JL.
    Br J Clin Pharmacol; 1984 May; 17(5):565-72. PubMed ID: 6145440
    [Abstract] [Full Text] [Related]

  • 6. The relationships between the cardiovascular effects, alpha- and beta-adrenoceptor blocking actions and plasma concentration of labetalol in doca hypertensive rats.
    Drew GM, Hilditch A, Levy GP.
    Clin Exp Hypertens (1978); 1979 May; 1(5):597-611. PubMed ID: 42517
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparative effects of adimolol, labetalol and propranolol on heart rate and blood pressure in man.
    Riddell JG, Harron DW, Shanks RG.
    Br J Clin Pharmacol; 1985 Apr; 19(4):405-10. PubMed ID: 2859871
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The dose dependency of the alpha-adrenoceptor antagonist and beta-adrenoceptor partial agonist activity of dilevalol and labetalol in man.
    Tham TC, McKaigue JP, Guy S, Shanks RG, Riddell JG.
    Br J Clin Pharmacol; 1993 Sep; 36(3):251-6. PubMed ID: 9114912
    [Abstract] [Full Text] [Related]

  • 11. Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects.
    Mehta J, Cohn JN.
    Circulation; 1977 Feb; 55(2):370-5. PubMed ID: 12880
    [Abstract] [Full Text] [Related]

  • 12. Pharmacology of combined alpha-beta-blockade. I.
    Louis WJ, McNeil JJ, Drummer OH.
    Drugs; 1984 Feb; 28 Suppl 2():16-34. PubMed ID: 6151889
    [Abstract] [Full Text] [Related]

  • 13. Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.
    Lund-Johansen P.
    Drugs; 1984 Feb; 28 Suppl 2():35-50. PubMed ID: 6151890
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Alpha- and beta-adrenoceptor blocking properties of labetalol in renin release.
    Lammintausta R, Koulu M, Allonen H.
    Int J Clin Pharmacol Biopharm; 1979 Jun; 17(6):240-43. PubMed ID: 38214
    [Abstract] [Full Text] [Related]

  • 16. Interdose control of beta-blockade and arterial blood pressure during chronic oral labetalol treatment.
    Sanders GL, Murray A, Rawlins MD.
    Br J Clin Pharmacol; 1979 Jun; 8(Suppl 2):125S-127S. PubMed ID: 43163
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Concurrent antagonism of isoproterenol and norepinephrine after labetalol.
    Richards DA, Prichard BN.
    Clin Pharmacol Ther; 1978 Mar; 23(3):253-8. PubMed ID: 627129
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.